Who Paid My Doc
A Phase 3, Multicenter, Randomized, Double-blind,
Research payments
$507,265
Through program year 2021, $507,265 in research payments was reported against A Phase 3, Multicenter, Randomized, Double-blind,, across 89 payments, paid by Celgene Corporation.
- Paid by
- Celgene Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $507,265 | 89 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Errol Korn Chula Vista, CA Named on 2 payments
- Deborah Proctor New Haven, CT Named on 2 payments
- John Gancayco Fort Sam Houston, TX Named on 2 payments
- Rohit Singhania Springfield, MA Named on 2 payments
- Jatinder Pruthi Lancaster, CA Named on 2 payments
- Bincy Abraham Houston, TX Named on 2 payments
- Randy Longman New York, NY Named on 2 payments
- Bryan Heath New Smyrna Beach, FL Named on 2 payments
- John Hanson Charlotte, NC Named on 2 payments
- Jessica Johnson Salt Lake City, UT Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.